文献速递腹部CT

CT检出的壁外血管侵犯与区域淋巴结受累预测T4a期胃癌无进展生存

CT-Detected Extramural Vessel Invasion and Regional Lymph Node Involvement in Stage T4a Gastric Cancer for Predicting Progression-Free Survival.
PubMed 文献 · AJR Am J Roentgenol · 2019-02-19

回顾性纳入143例T4a期胃癌患者,术前增强MDCT评估壁外血管侵犯(EMVI)及临床N分期,并与病理N分期对照。CT检出EMVI阳性率55.9%(80/143),EMVI阳性且N阳性组3年PFS为25.0%,显著低于其他三组;EMVI阳性-N阳性状态是3年PFS降低的独立因素(HR 2.169,95%CI 1.300-3.618,P=0.003)。

要点

  • 增强MDCT可检出T4a胃癌的壁外血管侵犯,阳性率55.9%(80/143)。
  • EMVI阳性且N阳性组3年PFS为25.0%,显著低于其他三组(P<0.05)。
  • EMVI阳性-N阳性是3年PFS降低的独立因素(HR 2.169,95%CI 1.300-3.618)。

核心结论

  • CT检出的EMVI联合增强MDCT检出的N状态,可作为T4a期胃癌患者有价值的术前预后因素。

研究设计与样本

  • 回顾性研究,纳入143例T4a期胃癌患者,术前均行增强MDCT临床分期,所有患者接受根治性胃切除术联合扩大淋巴结清扫、辅助化疗及常规随访。

关键影像表现/征象

  • CT检出EMVI的频率为55.9%(80/143)。
  • EMVI阳性-N阳性组3年PFS为25.0%,EMVI阳性-N阴性组为53.1%,EMVI阴性-N阳性组为75.6%,EMVI阴性-N阴性组为64.7%。
  • EMVI阳性-N阳性亚组的3年PFS率显著低于其他三组(P<0.05,log-rank检验)。

诊断标准与关键数值

  • 采用增强MDCT进行临床N分期及CT EMVI评估,以术后病理N分期为参照。
  • Cox比例风险回归显示EMVI阳性-N阳性状态是3年PFS降低的独立因素,HR为2.169(95%CI 1.300-3.618;P=0.003)。

临床应用与阅片要点

  • 术前增强MDCT报告中可同时评估EMVI与临床N状态,两者联合有助于识别3年PFS较差的T4a期胃癌患者。
  • EMVI阳性且N阳性的T4a期胃癌患者3年PFS率最低(25.0%),可作为术前预后分层依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. This study aimed to investigate the 3-year progression-free survival (PFS) of patients with stage T4a gastric cancer with extramural vessel invasion (EMVI) detected with contrast-enhanced (CE) MDCT. In addition, we investigated the possibility that CT of EMVI could improve clinical nodal (N) staging. MATERIALS AND METHODS. This retrospective study included 143 patients with T4a gastric cancer. Clinical staging was performed with CE-MDCT. All patients underwent radical gastrectomy with extended lymphadenectomy, adjuvant chemotherapy, and conventional follow-up visits. Potential prognostic factors, including CE-MDCT-detected N status, pathologic N status, EMVI detected at CT, tumor location or growth pattern, histologic type or tumor differentiation, and tumor size, were recorded. Survival estimates for PFS were obtained using the Kaplan-Meier product limit for the following patient subgroups: EMVI positive-N positive, EMVI positive-N negative, EMVI negative-N positive, and EMVI negative-N negative. Hazard ratios for 3-year PFS were generated using a Cox proportional hazard regression analysis. RESULTS. The frequency of EMVI detected at CT was 55.9% (80/143). The 3-year PFS rates were 25.0% for the EMVI positive-N positive group, 53.1% for the EMVI positive-N negative group, 75.6% for the EMVI negative-N positive group, and 64.7% for the EMVI negative-N negative group. The EMVI positive-N positive subgroup 3-year PFS rate was significantly lower than that of the other three groups (p < 0.05, log-rank test). Using Cox proportional hazards regression analysis, EMVI positive-N positive status was found to be an independent factor for reduced 3-year PFS, with a hazard ratio of 2.169 (95% CI, 1.300-3.618; p = 0.003). CONCLUSION. EMVI detected at CT, combined with N status detected with CE-MDCT, could be used as a valuable preoperative prognostic factor in patients with T4a gastric cancer.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Cheng J, Feng C, Zhang Y, et al. CT-Detected Extramural Vessel Invasion and Regional Lymph Node Involvement in Stage T4a Gastric Cancer for Predicting Progression-Free Survival. AJR Am J Roentgenol. 2019. PMID: 30779670. doi:10.2214/AJR.18.20342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。